Activation of Erk1/2 and Akt following unilateral ureteral obstruction

被引:85
作者
Rodriguez-Pena, Ana B. [1 ,2 ,3 ]
Grande, Maria T. [1 ,2 ]
Eleno, Nelida [1 ,2 ]
Arevalo, Miguel [4 ]
Guerrero, Carmen [3 ]
Santos, Eugerio [3 ]
Lopez-Novoa, Jose M. [1 ,2 ]
机构
[1] Univ Salamanca, Inst Reina Sofia Invest Nefrol, Dept Fisiol & Farmacol, Salamanca 37007, Spain
[2] Inst Carlos III, Salamanca 37007, Spain
[3] Univ Salamanca, Ctr Invest Canc, E-37008 Salamanca, Spain
[4] Univ Salamanca, Dept Anat & Histol Humanas, E-37008 Salamanca, Spain
关键词
chronic renal failure; tubulointerstitial fibrosis; ureteral ligation; apoptosis; proliferation; MAPK;
D O I
10.1038/ki.2008.160
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic unilateral ureteral obstruction is a well characterized model of renal injury leading to tubulointerstitial fibrosis and distinct patterns of cell proliferation and apoptosis in the obstructed kidney. In this study we assessed the contribution of the mitogen activated protein kinase (MAPK)-ERK1/2 and the phosphatidylinositol 3 kinase (PI3K)-Akt pathways to early renal changes following unilateral obstruction. Increased activation of small Ras GTPase and its downstream effectors ERK1/2 and Akt was detected in ligated kidneys. The use of specific pharmacological inhibitors to either ERK1/2 or Akt activation led to decreased levels of fibroblastmyofibroblast markers in the interstitium while inhibition of PI3K reduced the number of proliferating cells and the amount of interstitial extracellular matrix deposition. Treatment with an ERK1/2 inhibitor diminished the number of apoptotic tubule and interstitial cells. Our results suggest a role for the MAPK-ERK1/2 and PI3K-Akt systems in early changes induced by ureteral obstruction and that inhibition of these signaling pathways may provide a novel approach to prevent progression of renal fibrosis.
引用
收藏
页码:196 / 209
页数:14
相关论文
共 37 条
[1]   Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells [J].
Arany, I ;
Megyesi, JK ;
Kaneto, H ;
Price, PM ;
Safirstein, RL .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) :F543-F549
[2]  
Bohle A, 1996, KIDNEY INT, V49, pS2
[3]   In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis [J].
Bokemeyer, D ;
Panek, D ;
Kramer, HJ ;
Lindemann, M ;
Kitahara, M ;
Boor, P ;
Kerjaschki, D ;
Trzaskos, JM ;
Floege, J ;
Ostendorf, T .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06) :1473-1480
[4]  
Bokemeyer D, 2000, J AM SOC NEPHROL, V11, P232, DOI 10.1681/ASN.V112232
[5]   Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats [J].
Bokemeyer, D ;
Guglielmi, KE ;
McGinty, A ;
Sorokin, A ;
Lianos, EA ;
Dunn, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :582-588
[6]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[7]   MAPK activation determines renal epithelial cell survival during oxidative injury [J].
Di Mari, JF ;
Davis, R ;
Safirstein, RL .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (02) :F195-F203
[8]   MACROPHAGES, MONOCYTE CHEMOATTRACTANT PEPTIDE-1, AND TGF-BETA-1 IN EXPERIMENTAL HYDRONEPHROSIS [J].
DIAMOND, JR ;
KEESFOLTS, D ;
DING, GH ;
FRYE, JE ;
RESTREPO, NC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :F926-F933
[9]   Activation of renal signaling pathways in db/db mice with type 2 diabetes [J].
Feliers, D ;
Duraisamy, S ;
Faulkner, JL ;
Duch, J ;
Lee, AV ;
Abboud, HE ;
Choudhury, GG ;
Kasinath, BS .
KIDNEY INTERNATIONAL, 2001, 60 (02) :495-504
[10]   Hypertension: Our major challenges [J].
Frohlich, ED .
HYPERTENSION, 2001, 38 (05) :990-991